Company intelligence / Profile preview
Bioventus
Durham, North Carolina, United Statesbioventus.com ↗
- Ownership
- Public · BVS
- Employees
- ~1200
- Development stage
- Other
01
Overview
Bioventus markets a broad portfolio of commercial-stage products in three main segments—Pain Treatments, Restorative Therapies, and Surgical Solutions. Its key offerings include the StimRouter PNS system for chronic peripheral nerve pain; EXOGEN Ultrasound Bone Healing System for fracture repair; hyaluronic acid-based joint injection therapies; and a comprehensive suite of surgical orthobiologic bone graft solutions. The company’s products are supported by clinical data demonstrating efficacy in improving mobility and reducing the need for invasive procedures.
- Therapeutic areas
- RheumatologyNeurologyOther
- Modalities
- DeviceBiologicUltrasound-based therapySmall moleculeNeuromodulation device
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Distribution agreements with healthcare organizations globally
04
Financials
- Market cap
- $731.3M
- Total revenue
- $568.1M
- Enterprise value
- $944.7M
Beyond the preview
Go deeper on Bioventus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioventus.